Similar articles

• Is routine ultrasound guidance really necessary for closure of patent foramen ovale using the Amplatzer PFO occluder?

  Fateh-Moghadam S, Steeg M, Dietz R, Bocksch W. Fateh-Moghadam S, et al. Catheter Cardiovasc Interv. 2009 Feb 15;73(3):361-6. doi: 10.1002/ccd.21859. Catheter Cardiovasc Interv. 2009. PMID: 19133676
• Safety and feasibility of day case patent foramen ovale (PFO) closure facilitated by intracardiac echocardiography.

  Ponnuthurai FA, van Gaal WJ, Burchell A, Mitchell AR, Wilson N, Ormerod OJ. Ponnuthurai FA, et al. Int J Cardiol. 2009 Jan 24;131(3):438-40. doi: 10.1016/j.ijcard.2007.07.141. Epub 2007 Nov 26. Int J Cardiol. 2009. PMID: 18037512
• Image guidance for PFO closure: is transnasal TEE an option?

  Carroll JD. Carroll JD. Catheter Cardiovasc Interv. 2008 Oct 1;72(4):542-3. doi: 10.1002/ccd.21783. Catheter Cardiovasc Interv. 2008. PMID: 18819145 No abstract available.
• Echocardiographic assessment of percutaneous patent foramen ovale and atrial septal defect closure complications.

  Yared K, Baggish AL, Solis J, Durst R, Passeri JJ, Palacios IF, Picard MH. Yared K, et al. Circ Cardiovasc Imaging. 2009 Mar;2(2):141-9. doi: 10.1161/CIRCIMAGING.108.832436. Circ Cardiovasc Imaging. 2009. PMID: 19808580 Review. No abstract available.
• Percutaneous closure of patent foramen ovale with a novel FlatStent.

  Reiffenstein I, Majunke N, Wunderlich N, Carter P, Jones R, Sievert H. Reiffenstein I, et al. Expert Rev Med Devices. 2008 Jul;5(4):419-25. doi: 10.1586/17434440.5.4.419. Expert Rev Med Devices. 2008. PMID: 18573042 Review.